Ballesteros MP - Search Results

1

Drug Stability: ICH versus Accelerated Predictive Stability Studies.

González-González O, Ramirez IO, Ramirez BI, O'Connell P, Ballesteros MP, Torrado JJ, Serrano DR. González-González O, et al. Among authors: ballesteros mp. Pharmaceutics. 2022 Oct 28;14(11):2324. doi: 10.3390/pharmaceutics14112324. Pharmaceutics. 2022. PMID: 36365143 Free PMC article. Review.

2

Amphotericin B formulations and drug targeting.

Torrado JJ, Espada R, Ballesteros MP, Torrado-Santiago S. Torrado JJ, et al. Among authors: ballesteros mp. J Pharm Sci. 2008 Jul;97(7):2405-25. doi: 10.1002/jps.21179. J Pharm Sci. 2008. PMID: 17893903 Review.

3

HPLC assay for determination of amphotericin B in biological samples.

Espada R, Josa JM, Valdespina S, Dea MA, Ballesteros MP, Alunda JM, Torrado JJ. Espada R, et al. Among authors: ballesteros mp. Biomed Chromatogr. 2008 Apr;22(4):402-7. doi: 10.1002/bmc.947. Biomed Chromatogr. 2008. PMID: 18059059

4

In vivo distribution and therapeutic efficacy of a novel amphotericin B poly-aggregated formulation.

Espada R, Valdespina S, Dea MA, Molero G, Ballesteros MP, Bolás F, Torrado JJ. Espada R, et al. Among authors: ballesteros mp. J Antimicrob Chemother. 2008 May;61(5):1125-31. doi: 10.1093/jac/dkn048. Epub 2008 Feb 19. J Antimicrob Chemother. 2008. PMID: 18285313

5

Efficacy of alternative dosing regimens of poly-aggregated amphotericin B.

Espada R, Valdespina S, Molero G, Dea MA, Ballesteros MP, Torrado JJ. Espada R, et al. Among authors: ballesteros mp. Int J Antimicrob Agents. 2008 Jul;32(1):55-61. doi: 10.1016/j.ijantimicag.2008.02.025. Epub 2008 Jun 4. Int J Antimicrob Agents. 2008. PMID: 18534826

6

Effect of aggregation state on the toxicity of different amphotericin B preparations.

Espada R, Valdespina S, Alfonso C, Rivas G, Ballesteros MP, Torrado JJ. Espada R, et al. Among authors: ballesteros mp. Int J Pharm. 2008 Sep 1;361(1-2):64-9. doi: 10.1016/j.ijpharm.2008.05.013. Epub 2008 May 20. Int J Pharm. 2008. PMID: 18599228

7

A novel formulation of solubilised amphotericin B designed for ophthalmic use.

Serrano DR, Ruiz-Saldaña HK, Molero G, Ballesteros MP, Torrado JJ. Serrano DR, et al. Among authors: ballesteros mp. Int J Pharm. 2012 Nov 1;437(1-2):80-2. doi: 10.1016/j.ijpharm.2012.07.065. Epub 2012 Aug 4. Int J Pharm. 2012. PMID: 22890190

8

Hemolytic and pharmacokinetic studies of liposomal and particulate amphotericin B formulations.

Serrano DR, Hernández L, Fleire L, González-Alvarez I, Montoya A, Ballesteros MP, Dea-Ayuela MA, Miró G, Bolás-Fernández F, Torrado JJ. Serrano DR, et al. Among authors: ballesteros mp. Int J Pharm. 2013 Apr 15;447(1-2):38-46. doi: 10.1016/j.ijpharm.2013.02.038. Epub 2013 Feb 21. Int J Pharm. 2013. PMID: 23438978

9

Oral particle uptake and organ targeting drives the activity of amphotericin B nanoparticles.

Serrano DR, Lalatsa A, Dea-Ayuela MA, Bilbao-Ramos PE, Garrett NL, Moger J, Guarro J, Capilla J, Ballesteros MP, Schätzlein AG, Bolás F, Torrado JJ, Uchegbu IF. Serrano DR, et al. Among authors: ballesteros mp. Mol Pharm. 2015 Feb 2;12(2):420-31. doi: 10.1021/mp500527x. Epub 2015 Jan 15. Mol Pharm. 2015. PMID: 25558881 Free article.

10

A novel performing PEG-cholane nanoformulation for Amphotericin B delivery.

Luengo-Alonso C, Torrado JJ, Ballesteros MP, Malfanti A, Bersani S, Salmaso S, Caliceti P. Luengo-Alonso C, et al. Among authors: ballesteros mp. Int J Pharm. 2015 Nov 10;495(1):41-51. doi: 10.1016/j.ijpharm.2015.08.070. Epub 2015 Aug 28. Int J Pharm. 2015. PMID: 26319629

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38 results

Search Page